Atrial fibrillation in heart failure: High mortality risk even if ventricular function is preserved

被引:38
作者
Parkash, R
Maisel, WH
Toca, FM
Stevenson, WG
机构
[1] Queen Elizabeth 2 Hlth Sci Ctr, Div Cardiol, Halifax, NS B3H 3A7, Canada
[2] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
关键词
D O I
10.1016/j.ahj.2004.12.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The purpose of this study was to determine if patients with atrial fibrillation (AF) and heart failure (HF) have a better prognosis when systolic function is preserved as compared with those with depressed systolic function. Methods Data from consecutive patients presenting to the emergency department at Brigham and Women's Hospital from January 1997 to December 2002 who had a diagnosis of AF and HF and a measure of ejection fraction (EF) were reviewed. Vital status was determined from the Social Security Death Index. Results Of 478 patients (mean age 74 +/- 13 years; 47% women), EF was preserved (>50%) in 46%. Those with preserved left ventricular (LV) function were older (76 vs 72 years, P<.0020), included more women (62 vs 35%, P<.0001), more likely to have a history of hypertension and pulmonary disease and less likely to have had a prior myocardial infarction. At 5 years, mortality was similar between the preserved and depressed EF groups (50% vs 48%, P =.74). In multivariable analysis, age > 75 years, history of cancer, cerebrovascular disease, aortic valve disease, serum creatinine > 2.0 mg/dL, and serum sodium < 130 mmol/L were associated with increased mortality. Therapy with beta-blockers and angiotensin-converting enzyme inhibitors/angiotensin receptor blocker were associated with lower mortality. Conclusion Patients who present to the emergency department with AF, HF, and preserved LVEF have a similarly high mortality as compared with those with depressed LVEF. Further study is needed to assess the impact of therapies and clarify the reasons for the poor prognosis.
引用
收藏
页码:701 / 706
页数:6
相关论文
共 31 条
[1]  
*AM HEART ASS, 2003, HEART DIS STROK STAT
[2]   Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction [J].
Badano, LP ;
Albanese, MC ;
De Biaggio, P ;
Rozbowsky, P ;
Miani, D ;
Fresco, C ;
Fioretti, PM .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2004, 17 (03) :253-261
[3]   INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY [J].
BENJAMIN, EJ ;
LEVY, D ;
VAZIRI, SM ;
DAGOSTINO, RB ;
BELANGER, AJ ;
WOLF, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11) :840-844
[4]  
CARSON PE, 1993, CIRCULATION, V87, P102
[5]  
Cioffi G, 1996, EUR HEART J, V17, P1381
[6]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[7]   Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study [J].
Corley, SD ;
Epstein, AE ;
DiMarco, JP ;
Domanski, MJ ;
Geller, N ;
Greene, HL ;
Josephson, RA ;
Kellen, JC ;
Klein, RC ;
Krahn, AD ;
Mickel, M ;
Mitchell, LB ;
Nelson, JD ;
Rosenberg, Y ;
Schron, E ;
Shemanski, L ;
Waldo, AL ;
Wyse, DG .
CIRCULATION, 2004, 109 (12) :1509-1513
[8]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[9]   Long-term survival in patients hospitalized with congestive heart failure:: relation to preserved and reduced left ventricular systolic function [J].
Gustafsson, F ;
Torp-Pedersen, C ;
Brendorp, B ;
Seibæk, M ;
Burchardt, H ;
Kober, L .
EUROPEAN HEART JOURNAL, 2003, 24 (09) :863-870
[10]   Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure [J].
Kalantar-Zadeh, K ;
Block, G ;
Horwich, T ;
Fonarow, GC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (08) :1439-1444